Bayesian Capital Management’s Ardelyx ARDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$56.6K Buy
+11,100
New +$67.8K 0.04% 221
2025
Q2
Sell
-18,900
Closed -$92.8K 541
2025
Q1
$92.8K Sell
18,900
-31,500
-63% -$169K 0.02% 548
2024
Q4
$256K Buy
+50,400
New +$278K 0.03% 516
2024
Q2
Sell
-90,049
Closed -$657K 718
2024
Q1
$657K Buy
+90,049
New +$770K 0.06% 382
2023
Q4
Sell
-96,149
Closed -$392K 737
2023
Q3
$392K Buy
96,149
+64,400
+203% +$251K 0.04% 417
2023
Q2
$108K Sell
31,749
-123,100
-79% -$505K 0.01% 686
2023
Q1
$742K Buy
154,849
+138,149
+827% +$466K 0.09% 294
2022
Q4
$47.6K Buy
+16,700
New +$28.3K 0.01% 706

Other funds holding ARDX

Bayesian Capital Management's ARDX Position: Q2 2026 in Review

Bayesian Capital Management opened a new position in Ardelyx (ARDX) in Q2 2026: 11,100 shares worth $56.6K. The stake represents 0.04% of the portfolio and ranks #221 among its holdings. This is a return to the name: Bayesian Capital Management previously reported a position in ARDX as recently as Q1 2025.

Bayesian Capital Management first reported a position in ARDX in Q4 2022 and has held it in 8 quarters since. The position peaked at $742K in Q1 2023. 250 funds tracked by Wall St. Rank hold ARDX as of Q2 2026.

  • Bayesian Capital Management held 11,100 shares of Ardelyx worth $56.6K as of Q2 2026.
  • Ardelyx was a new Bayesian Capital Management position in Q2 2026.
  • Ardelyx made up 0.04% of Bayesian Capital Management's portfolio in Q2 2026, its #221 holding.
  • Bayesian Capital Management first reported a position in Ardelyx in Q4 2022 and has held it in 8 quarters since.
  • Bayesian Capital Management's Ardelyx position peaked at $742K in Q1 2023.
  • 250 funds tracked by Wall St. Rank held Ardelyx as of Q2 2026.

Based on Bayesian Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.